Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Fatty liver disease packs a punch on wallets in flanders

NCT ID NCT05035043

First seen Jan 05, 2026 · Last updated Jun 22, 2026 · Updated 27 times

Summary

This completed study looked at the economic burden of non-alcoholic fatty liver disease (NAFLD) in 73 adults in Flanders, Belgium. Researchers measured healthcare costs, patient expenses, and quality of life using questionnaires. The goal was to understand the financial impact of the disease, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hasselt University

    Hasselt, 3500, Belgium

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.